Literature DB >> 16929177

The role of p53 in atherosclerosis.

John Mercer1, Martin Bennett.   

Abstract

Although the role of the tumor suppressor gene p53 is well known in cancer, recent studies have highlighted a fundamental role for p53 in regulating cells in the advanced atherosclerotic plaque, the major cause of heart attacks and stroke. In particular, p53 is activated in the complex environment of the plaque, in part by DNA damage within the lesion, and regulates growth arrest, cell senescence and apoptosis of vascular smooth muscle cells (VSMCs). The role of endogenous p53 has been determined using p53 knockout in mice developing advanced atherosclerosis, using bone marrow transplant to separate effects on blood cells from vessel wall cells. These studies have produced apparently contradictory and surprising results. In particular, recent studies have identified a role for endogenous p53 in protection of VSMCs from apoptosis, trans-differentiation of bone marrow stromal cells into VSMCs in atherosclerosis, and altering the mode of cell death in the plaque.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929177     DOI: 10.4161/cc.5.17.3166

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

Review 1.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

2.  LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity.

Authors:  Gengze Wu; Jin Cai; Yu Han; Jinghai Chen; Zhan-Peng Huang; Caiyu Chen; Yue Cai; Hefei Huang; Yujia Yang; Yukai Liu; Zaicheng Xu; Duofen He; Xiaoqun Zhang; Xiaoyun Hu; Luca Pinello; Dan Zhong; Fengtian He; Guo-Cheng Yuan; Da-Zhi Wang; Chunyu Zeng
Journal:  Circulation       Date:  2014-08-25       Impact factor: 29.690

Review 3.  Complicated atheromatous plaque as integral atherogenesis.

Authors:  Lawrence M Agius
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

Review 4.  Cellular senescence: from physiology to pathology.

Authors:  Daniel Muñoz-Espín; Manuel Serrano
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

5.  Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells.

Authors:  Chien-Hung Huang; Jin-Shuei Ciou; Shun-Tsung Chen; Victor C Kok; Yi Chung; Jeffrey J P Tsai; Nilubon Kurubanjerdjit; Chi-Ying F Huang; Ka-Lok Ng
Journal:  PeerJ       Date:  2016-09-28       Impact factor: 2.984

6.  Folic acid inhibits homocysteine-induced cell apoptosis in human umbilical vein endothelial cells.

Authors:  Shanshan Cui; Wen Li; Pengyan Wang; Xin Lv; Yuxia Gao; Guowei Huang
Journal:  Mol Cell Biochem       Date:  2017-12-18       Impact factor: 3.396

7.  Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.

Authors:  Nicholas J Leeper; Azad Raiesdana; Yoko Kojima; Ramendra K Kundu; Henry Cheng; Lars Maegdefessel; Ryuji Toh; G-One Ahn; Ziad A Ali; D Ryan Anderson; Clint L Miller; Scott C Roberts; Joshua M Spin; Patricia E de Almeida; Joseph C Wu; Baohui Xu; Karen Cheng; Maximilian Quertermous; Soumajit Kundu; Kim E Kortekaas; Erica Berzin; Kelly P Downing; Ronald L Dalman; Philip S Tsao; Eric E Schadt; Gary K Owens; Thomas Quertermous
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

8.  p53 is required for chloroquine-induced atheroprotection but not insulin sensitization.

Authors:  Babak Razani; Chu Feng; Clay F Semenkovich
Journal:  J Lipid Res       Date:  2010-03-05       Impact factor: 5.922

Review 9.  DNA damage, vascular senescence and atherosclerosis.

Authors:  Maria Grazia Andreassi
Journal:  J Mol Med (Berl)       Date:  2008-06-19       Impact factor: 4.599

10.  Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms.

Authors:  Saula Vigili de Kreutzenberg; Giulio Ceolotto; Italia Papparella; Alessia Bortoluzzi; Andrea Semplicini; Chiara Dalla Man; Claudio Cobelli; Gian Paolo Fadini; Angelo Avogaro
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.